1WU XueMei1,3 & XIAO HuaSheng1,2 1 Center of Functional Genomics,Key Laboratory of System Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai 200031,China,2 National Engineering Center for Biochip at Shanghai,Shanghai 201203,China,3 Graduate University of Chinese Academy of Sciences,Shanghai 200031,China.miRNAs modulate the drug response of tumor cells[J].Science China(Life Sciences),2009,52(9):797-801. 被引量：6
3Jeong HC. Clinical sped of micro-RNA in lung cancer[J]. Respir Dis(Seoul), 2014, 77(2):60-64.
4Wang XC, Tian LL, Wu HL, et al. Expression of miRNA-130a in nonsmall cell lung cance[J]. Am J Med Sci, 2010, 340(5):385-388.
5Kovalchuk O, Filkowski J, Meservy J, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to hemotherapeutic drug doxorubicin[J]. Mol Cancer Ther, 2008,7(7):2152-2159.
6Luo Q, Li X, Gao Y, et al. MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer[J]. Cancer Cell Int, 2013, 13(1):95.
7Guo ST, Jiang CC, Wang GP, et al.. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer[J]. Oncogene, 2013, 32(15):1910-1920.
